ESMO Clinical Practice Guidelines: Hereditary Syndromes
The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.
Latest enhanced and revised set of guidelines
ESMO has Clinical Practice Guidelines on the following Hereditary Syndromes: Prevention and Screening in BRCA Mutation Carriers and Other Breast/Ovarian Hereditary Cancer Syndromes. They include information on incidence, diagnosis, staging and risk assessment, treatment and response evaluation and follow-up.
Breast cancer , Gynaecologic malignancies
Prevention and Screening in BRCA Mutation Carriers and Other Breast/Ovarian Hereditary Cancer Syndromes: ESMO Clinical Practice Guidelines
Published in 2016 – Ann Oncol (2016) 27 (suppl 5): v103-v110
Authors: S. Paluch-Shimon, F. Cardoso, C. Sessa, J. Balmana, M. J. Cardoso, F. Gilbert and E. Senkus